NCT05884060View on ClinicalTrials.gov

Retrospective Chart Review Screening Algorithm to Assess the Prevalence of PNH-clones

CompletedOBSERVATIONAL
Enrollment

568

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
PNHThrombosis
Interventions
OTHER

No intervention

No interventions

Trial Locations (1)

8800

AZ Delta, Roeselare

Sponsors

Lead Sponsor

AZ Delta
All Listed Sponsors
collaborator

Alexion Pharmaceuticals, Inc.

INDUSTRY

lead

AZ Delta

OTHER